| |||||||||
|
Equine
Monoclonal antibodies will be made to: Cell Surface Molecules: CD25: monoclonal fusion completed May 2008 (Cornell); 1 mAb, became negative, will repeat fusion (Cornell) CD40: monoclonal fusion completed September 2008 (UMass Amherst); many positives currently in testing (Cornell) CD23: monoclonal fusion completed October 2008 (Cornell); 6 mAbs, contact Dr. Bettina Wagner, Cornell CD28: monoclonal fusion completed November 2008 (Cornell); 3 mAbs, contact Dr. Bettina Wagner, Cornell FcεRIα: fusion completed (Cornell); 3 mAbs, contact Dr. Bettina Wagner, Cornell TCRα: protein production planned June 2009; monoclonal antibody production planned July 2009 (Cornell) TCRγ: re-cloning into IL-4 vector (Cornell); fusion scheduled July 2009 (Cornell) TCRδ: protein production planned June 2009 (Cornell); monoclonal antibody production planned July 2009 (Cornell) IgD: protein production planned June 2009 (Cornell); monoclonal antibody production planned July 2009 (Cornell) Cytokines and Chemokines: IL-4: protein production planned November 2008 (Kingfisher); monoclonal antibody production planned Decemeber 2008 (Cornell) IL-2: protein production planned March 2009 (Kingfisher); monoclonal antibody production planned April 2009 (Cornell) IL-6: protein production planned April 2009 (Kingfisher); monoclonal antibody production planned May 2009 (Cornell) IL-8: no mAbs despite 3 fusions Click here to download the survey form. Last updated: August 2009 |
![]() Dr. Bettina Wagner Species Coordinator, Equine Species Coordinator Bettina Wagner Species Collaborators Douglas Antczak
James Belknap
Samuel Black
Steve Hines
Jeff Davis
Species Consultants Paul Lunn
John Butler
Marie-Paul Lefranc
|
||||||||
| | |||||||||